WallStSmart
ASBP

Aspire BioPharma, Inc.

NASDAQ: ASBP · CONSUMER CYCLICAL · AUTO PARTS

$8.88
+5.21% today

Updated 2026-10-28

Market cap
$11.80M
P/E ratio
—
P/S ratio
120.78x
EPS (TTM)
$-29.69
Dividend yield
—
52W range
$3 – $563
Volume
0.0M

Aspire BioPharma, Inc. (ASBP) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+2600.0%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+5.9%
Last 4 reports
Positive reaction rate
75%
3 of 4 quarters
Largest single-day move
+13.8%
2026-05-15
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-08-13$1.00—$7.13$7.85+10.1%
2026-05-15$-20.57—$5.87$6.68+13.8%
2026-03-30$-39.97—$0.91$1.03+12.8%
2025-11-14$-44.84—$0.11$0.09-13.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-06-30—$1.00—$63103.00—
2026-03-31—$-20.57—$28353.00—
2025-12-31—$-39.97—$4261.00—
2025-09-30—$-44.84—$1941.00—
2025-06-30—$-0.04———
2025-03-31—$-0.42———
2024-12-31—$-1.15———
2024-09-30—$-82.99———
2024-06-30—$-85.37———
2024-03-31—$-329.27———

Frequently asked questions

Has Aspire BioPharma, Inc. beaten earnings estimates?

Aspire BioPharma, Inc. has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does ASBP stock react to earnings?

ASBP has moved an average of +5.9% the day after earnings over its last 4 reports, finishing higher after 3 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.